<code id='38BA473E86'></code><style id='38BA473E86'></style>
      • <acronym id='38BA473E86'></acronym>
      <center id='38BA473E86'><center id='38BA473E86'><tfoot id='38BA473E86'></tfoot></center><abbr id='38BA473E86'><dir id='38BA473E86'><tfoot id='38BA473E86'></tfoot><noframes id='38BA473E86'>
      • <optgroup id='38BA473E86'><strike id='38BA473E86'><sup id='38BA473E86'></sup></strike><code id='38BA473E86'></code></optgroup>
        5. <b id='38BA473E86'><label id='38BA473E86'><select id='38BA473E86'><dt id='38BA473E86'><span id='38BA473E86'></span></dt></select></label></b><u id='38BA473E86'></u>
          <i id='38BA473E86'><strike id='38BA473E86'><tt id='38BA473E86'><pre id='38BA473E86'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / Wikipedia / leisure time      
           
     
           
      
          leisure time 
           
      
           
      
           
       2025-09-30 07:28:18 
   
      
           
      
           
                        
          leisure time  
          
                                   
                 
                                      author：entertainment   
                                        
                                      
                                      Page View：9
                                  
                                    
          
                                   
          Adam's take main illustration
          Molly Ferguson/STAT
          Biotech is awash in PIPEs.
          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.
          advertisement
          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma
                                
                            
          Next article：  
                                      
                                          23andMe had bad news about my health. I wish a person had delivered it
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles